Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

Similar articles for PubMed (Select 23944718)

1.

Bulls, bubbles, and biotech.

Wilson JM.

Hum Gene Ther. 2013 Aug;24(8):715-6. doi: 10.1089/hum.2013.2509. No abstract available.

PMID:
23944718
2.

Evolving paradigms in biotech IPO valuations.

Papadopoulos S.

Nat Biotechnol. 2001 Jul;19 Suppl:BE18-9. No abstract available.

PMID:
11433243
3.

Delisting threat looms large on biotech front.

Lawrence S.

Nat Biotechnol. 2005 Jan;23(1):5. No abstract available.

PMID:
15637598
4.

Nasdaq dilutes its biotech index.

Dorey E.

Nat Biotechnol. 2004 Jan;22(1):9. No abstract available.

PMID:
14704690
5.

State of the biotech sector - 2006.

Lawrence S.

Nat Biotechnol. 2007 Jul;25(7):706. No abstract available.

PMID:
17621283
6.

Investment relief for biotech sector.

Ledford H.

Nature. 2012 Nov 15;491(7424):316. doi: 10.1038/491316a. No abstract available.

PMID:
23151557
7.

PEGging biotech growth.

Jacobs T.

Nat Biotechnol. 2006 May;24(5):506. No abstract available.

PMID:
16680127
8.

Biotech boom prompts fears of bust.

Ledford H.

Nature. 2013 Aug 29;500(7464):513. doi: 10.1038/500513a. No abstract available.

PMID:
23985852
9.

Hedge funds gain edge by doubling biotech investments.

Ransom J.

Nat Biotechnol. 2006 Apr;24(4):373-4. No abstract available.

PMID:
16601707
10.

Biotech equities heat up in 1Q12.

Yang W.

Nat Biotechnol. 2012 May 7;30(5):384. doi: 10.1038/nbt.2211. No abstract available.

PMID:
22565955
11.

Biotech meets the investors.

Berry S.

Trends Biotechnol. 2002 Sep;20(9):370-1. No abstract available.

PMID:
12175762
12.

The number on biotech indexes.

Jacobs T.

Nat Biotechnol. 2005 Nov;23(11):1356. No abstract available.

PMID:
16273059
13.

Biotech marks time in Q3.

Lawrence S.

Nat Biotechnol. 2005 Nov;23(11):1332. No abstract available.

PMID:
16273049
14.

Tough times set to continue for US biotech start-ups.

Lehrman S.

Nature. 1999 Jan 21;397(6716):191. No abstract available.

PMID:
9930684
15.

Biotech holds its own in Q2.

Lawrence S.

Nat Biotechnol. 2004 Aug;22(8):938. No abstract available.

PMID:
15286634
16.

US government previews biotech survey.

Goho A.

Nat Biotechnol. 2003 Aug;21(8):837-8. No abstract available.

PMID:
12894185
17.

Is your biotech giving away the store?

Jacobs T.

Nat Biotechnol. 2002 Nov;20(11):1079. No abstract available.

PMID:
12410245
18.

Hwang scandal hits Korean biotech hard.

Fuyuno I.

Nature. 2006 Jan 19;439(7074):265. No abstract available.

PMID:
16421542
19.

Scientists and societies. The Polish biotech gap.

Gorlach S, Slabicki M.

Nature. 2004 Feb 26;427(6977):870. No abstract available.

PMID:
14985771
20.

Crystal gazing: biotech's financial outlook: the biotech analyst's view.

Schmidt E.

Nat Biotechnol. 2006 Mar;24(3):261-2. No abstract available.

PMID:
16525376
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk